Melvin L.K. Chua, Professor at Duke-NUS Medical School, shared on LinkedIn:
“Not often do we publish 2 back to back guidelines on Nasopharyngeal Carcinoma in the Journal of Clinical Oncology.
Was a pleasure leading this monumental effort with Brigette B.Y. Ma, American Society of Clinical Oncology (ASCO), Chinese Society of Clinical Oncology (CSCO).
-
Title: Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update
Authors: Yu-Pei Chen, Nofisat Ismaila, Shao Hui Huang, Wei Jiang, Brigette Ma, Robert Haddad, Quynh-Thu Le, A. Dimitrios Colevas, Kevin Harrington, Sue S. Yom, Brian O’Sullivan, Anthony T.C. Chan, Annie Chan, Nancy Lee, Anne W.M. Lee, Jun-Lin Yi, Chao-Su Hu, Kun-Yu Yang, Qin Lin, Alexander C. Whitley, Jin-Ching Lin, Shu Wing Jack Lam, Yosephtri Siahaan, Melvin L.K. Chua, Jun Ma, Ying Sun
-
Title: Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma: CSCO and ASCO Joint Guideline
Authors: Wei Jiang, Nofisat Ismaila, Melvin L.K. Chua, Robert Haddad, Quynh-Thu Le, A. Dimitrios Colevas, Nabil F. Saba, Kevin Harrington, Shao Hui Huang, Anthony T.C. Chan, Christine H. Chung, Gregorius Ben Prajogi, Wan Zamaniah Wan Ishak, Lillian L. Siu, Wen-Feng Fang, Song Qu, Su-Fang Qiu, Yi-Jun Hua, Qing-Qing Cai, Alexander C. Whitley, Shu Wing Jack Lam, Yosephtri Siahaan, Brigette Ma, Yu-Pei Chen, Jun Ma
You can also read:
Melvin L.K. Chua: Defining Where Proton Beam Therapy Benefits Nasopharyngeal Carcinoma